文献速递泌尿系结石

基于结石与软组织识别控制激光发射的激光系统临床前评估

Pre-clinical evaluation of a laser system with emission control based on stone vs soft tissue recognition.
PubMed 文献 · BJU Int · 2026-05-31

本研究评估集成于铥光纤激光器的StoneSense™模块(SSM)实时目标识别单元。离体实验显示SSM完全防止软组织消融,结石消融效率仅降低2.75%和3%,识别灵敏度100%、特异度达98%;在体实验实现所有结石类型完全粉末化且无黏膜损伤。

要点

  • SSM可实时识别结石与软组织,阻止对软组织发射激光。
  • 离体实验软组织消融完全避免,结石消融效率仅轻微降低。
  • 在体实验实现完全粉末化,无黏膜损伤,识别性能高。

核心结论

  • 将基于背反射光谱的激光发射控制集成于铥光纤激光碎石系统可行且有效。
  • SSM实现精准实时结石识别,减少不必要激光发射,保持粉末化效率。

研究设计与样本

  • 离体实验:人工BegoStone结石嵌入猪肾组织,能量0.1-2 J、5-100 Hz,光纤扫描速度1和3 mm/s;人结石在2和5 mm/s、0.5 J×20 Hz下测试。
  • 在体实验:猪尿路中预植入人结石行碎石术。
  • 主要结局:消融效率及结石识别的灵敏度和特异度。

主要发现

  • 离体实验中软组织消融完全被防止,结石平均消融减少在1和3 mm/s分别为2.75%和3%。
  • 系统抑制激光对软组织发射的灵敏度100%,特异度高达98%。
  • 在体实验中所有结石类型实现完全粉末化(碎片<500 μm),无可见黏膜损伤。
  • 在体特异度85%-100%,灵敏度90%-100%。

关键数值与推荐

  • SSM在 incoming 信号来自组织或光纤到目标距离大于预设阈值(通常≥2-4 mm)时停止激光发射。
  • 离体结石消融减少:1 mm/s为2.75%,3 mm/s为3%。
  • 离体识别灵敏度100%,特异度高达98%;在体特异度85%-100%,灵敏度90%-100%。
  • 在体完全粉末化碎片<500 μm,无黏膜损伤。

临床怎么用

  • SSM可在碎石过程中实时识别结石与软组织,防止对软组织误发射激光。
  • 该技术保持粉末化效率,减少不必要的激光发射,有望提高安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the feasibility and performance of the StoneSense™ module (SSM; IPG Medical, Marlborough, MA, USA), a prototype real-time target recognition unit integrated into a IPG Thulium Fiber Laser (TFL). MATERIALS AND METHODS: The SSM analyses the spectral signature of back reflected light-emitting diode (LED) light from the target, stopping laser energy emission when incoming signal is originating from tissue or when the fibre-to-target distance is larger than pre-defined threshold (typically, ≥2-4 mm). The ex vivo tests were conducted on artificial BegoStone phantoms ((Bego GmbH & Co. KG, Bremen, Germany) embedded in porcine kidney tissue using energy settings of 0.1-2 J and 5-100 Hz at two fibre-scanning speeds (1 and 3 mm/s) through a translation stage movement. Human urinary stones were subsequently tested at 2 and 5 mm/s with setting of 0.5 J × 20 Hz. The in vivo trial was conducted by lithotripsy of pre-implanted human stones in porcine urinary tract. Primary outcome measures included ablation efficiency as well as specificity and sensitivity of stone recognition. RESULTS: Soft tissue ablation was completely prevented in all the ex vivo trials while maintaining high lithotripsy efficiency. Mean stone ablation reduction was 2.75% and 3% at fibre scanning speeds of 1 and 3 mm/s, respectively. The system achieved 100% sensitivity and up to 98% specificity in inhibiting laser emission to soft tissue. In vivo, complete dusting with fragments <500 μm was achieved for all studied stone types without observable mucosal injury. Specificity ranged from 85% to 100%, while sensitivity ranged from 90% to 100%. CONCLUSIONS: Integration of back reflected-light-spectra-based laser emission control into a TFL-based lithotripsy system is feasible and effective. The SSM enables precise real-time stone recognition, minimises unnecessary lasing, and preserves dusting efficiency.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Traxer O, Zorzi F, Yaroslavsky IV, et al. Pre-clinical evaluation of a laser system with emission control based on stone vs soft tissue recognition. BJU Int. 2026. PMID: 42219295. doi:10.1111/bju.70301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。